N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine

C94H75BrF17N23O5 — CID 159557717

IUPACN-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine
SMILESCOc1cc(Nc2ccc(C(F)(F)F)cc2)nc(-c2c(C(F)(F)F)nc3ccccn23)c1.COc1ccc(Nc2cccc(-c3c(C(F)(F)F)nc4ccc(OC)cn34)n2)cc1.Cc1nn(C)c(C)c1-c1cncc(Nc2ccc(Br)cc2)n1.Cc1nn(C)c(C)c1-c1cncc(Nc2ccc(OC(F)(F)F)cc2)n1.FC(F)Oc1ccc(Nc2cccc(-c3c(C(F)(F)F)nc4ncccn34)n2)cc1
InChIInChI=1S/C21H14F6N4O.C21H17F3N4O2.C19H12F5N5O.C17H16F3N5O.C16H16BrN5/c1-32-14-10-15(18-19(21(25,26)27)30-17-4-2-3-9-31(17)18)29-16(11-14)28-13-7-5-12(6-8-13)20(22,23)24;1-29-14-8-6-13(7-9-14)25-17-5-3-4-16(26-17)19-20(21(22,23)24)27-18-11-10-15(30-2)12-28(18)19;20-17(21)30-12-7-5-11(6-8-12)26-14-4-1-3-13(27-14)15-16(19(22,23)24)28-18-25-9-2-10-29(15)18;1-10-16(11(2)25(3)24-10)14-8-21-9-15(23-14)22-12-4-6-13(7-5-12)26-17(18,19)20;1-10-16(11(2)22(3)21-10)14-8-18-9-15(20-14)19-13-6-4-12(17)5-7-13/h2-11H,1H3,(H,28,29);3-12H,1-2H3,(H,25,26);1-10,17H,(H,26,27);4-9H,1-3H3,(H,22,23);4-9H,1-3H3,(H,19,20)
InChIKeyMGEZHJYELHDKIL-UHFFFAOYSA-N
MW2009.66 g/mol
LogP24.65
Rot. Bonds21

About N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine

N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine (PubChem CID 159557717) has the molecular formula C94H75BrF17N23O5 and a molecular weight of 2009.66 g/mol. Its IUPAC name is N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine.

Molecular Properties

Compound NameN-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine
PubChem CID159557717
Molecular FormulaC94H75BrF17N23O5
Molecular Weight2009.66 g/mol
Exact Mass2007.52
IUPAC NameN-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine
SMILESCOc1cc(Nc2ccc(C(F)(F)F)cc2)nc(-c2c(C(F)(F)F)nc3ccccn23)c1.COc1ccc(Nc2cccc(-c3c(C(F)(F)F)nc4ccc(OC)cn34)n2)cc1.Cc1nn(C)c(C)c1-c1cncc(Nc2ccc(Br)cc2)n1.Cc1nn(C)c(C)c1-c1cncc(Nc2ccc(OC(F)(F)F)cc2)n1.FC(F)Oc1ccc(Nc2cccc(-c3c(C(F)(F)F)nc4ncccn34)n2)cc1
InChIInChI=1S/C21H14F6N4O.C21H17F3N4O2.C19H12F5N5O.C17H16F3N5O.C16H16BrN5/c1-32-14-10-15(18-19(21(25,26)27)30-17-4-2-3-9-31(17)18)29-16(11-14)28-13-7-5-12(6-8-13)20(22,23)24;1-29-14-8-6-13(7-9-14)25-17-5-3-4-16(26-17)19-20(21(22,23)24)27-18-11-10-15(30-2)12-28(18)19;20-17(21)30-12-7-5-11(6-8-12)26-14-4-1-3-13(27-14)15-16(19(22,23)24)28-18-25-9-2-10-29(15)18;1-10-16(11(2)25(3)24-10)14-8-21-9-15(23-14)22-12-4-6-13(7-5-12)26-17(18,19)20;1-10-16(11(2)22(3)21-10)14-8-18-9-15(20-14)19-13-6-4-12(17)5-7-13/h2-11H,1H3,(H,28,29);3-12H,1-2H3,(H,25,26);1-10,17H,(H,26,27);4-9H,1-3H3,(H,22,23);4-9H,1-3H3,(H,19,20)
InChIKeyMGEZHJYELHDKIL-UHFFFAOYSA-N
XLogP24.65
TPSA296.96 Ų
H-Bond Donors5
H-Bond Acceptors28
Rotatable Bonds21
Heavy Atoms140
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002009.66
LogP ≤ 524.65
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1028

Analyze N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine?
The IUPAC name of N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine (CID 159557717) is N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine.
What is the SMILES notation for N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine?
The canonical SMILES for N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine is COc1cc(Nc2ccc(C(F)(F)F)cc2)nc(-c2c(C(F)(F)F)nc3ccccn23)c1.COc1ccc(Nc2cccc(-c3c(C(F)(F)F)nc4ccc(OC)cn34)n2)cc1.Cc1nn(C)c(C)c1-c1cncc(Nc2ccc(Br)cc2)n1.Cc1nn(C)c(C)c1-c1cncc(Nc2ccc(OC(F)(F)F)cc2)n1.FC(F)Oc1ccc(Nc2cccc(-c3c(C(F)(F)F)nc4ncccn34)n2)cc1.
What is the InChIKey of N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine?
The InChIKey is MGEZHJYELHDKIL-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H14F6N4O.C21H17F3N4O2.C19H12F5N5O.C17H16F3N5O.C16H16BrN5/c1-32-14-10-15(18-19(21(25,26)27)30-17-4-2-3-9-31(17)18)29-16(11-14)28-13-7-5-12(6-8-13)20(22,23)24;1-29-14-8-6-13(7-9-14)25-17-5-3-4-16(26-17)19-20(21(22,23)24)27-18-11-10-15(30-2)12-28(18)19;20-17(21)30-12-7-5-11(6-8-12)26-14-4-1-3-13(27-14)15-16(19(22,23)24)28-18-25-9-2-10-29(15)18;1-10-16(11(2)25(3)24-10)14-8-21-9-15(23-14)22-12-4-6-13(7-5-12)26-17(18,19)20;1-10-16(11(2)22(3)21-10)14-8-18-9-15(20-14)19-13-6-4-12(17)5-7-13/h2-11H,1H3,(H,28,29);3-12H,1-2H3,(H,25,26);1-10,17H,(H,26,27);4-9H,1-3H3,(H,22,23);4-9H,1-3H3,(H,19,20).
What are the key properties of N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine?
N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine has a molecular weight of 2009.66 g/mol, XLogP of 24.65, 21 rotatable bonds, 5 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-bromophenyl)-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine;N-[4-(difluoromethoxy)phenyl]-6-[2-(trifluoromethyl)imidazo[1,2-a]pyrimidin-3-yl]pyridin-2-amine;N-(4-methoxyphenyl)-6-[6-methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine;4-methoxy-6-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[4-(trifluoromethyl)phenyl]pyridin-2-amine;N-[4-(trifluoromethoxy)phenyl]-6-(1,3,5-trimethylpyrazol-4-yl)pyrazin-2-amine is sourced from PubChem (CID 159557717), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).